首页
品牌
ELISA试剂盒
抗体抗原
公司新闻
技术文章
关于拜力
留言询价
产品资料
首页
>>>
产品目录
>>>
中国授权代理品牌
>>> 
Innov-Research
Human Angiostatin
点击看大图
如果您对该产品感兴趣的话,可以
产品名称:
Human Angiostatin
产品型号:
IRANGSTN
产品展商:
Innov-Research
产品文档:
无相关文档
简单介绍
Human Angiostatin
Human Angiostatin
的详细介绍
Product Description
Human Angiostatin
Angiostatin is a single-chain, proteolytic fragment of glu-plasminogen which has a molecular weight of about 38,000. It is a potent inhibitor of angiogenesis and was first identified and isolated from the serum and urine of tumor bearing mice. The mouse protein reportedly extends from threonine-98 through valine-440 (numbering from the NH2-terminus of glu-plasminogen). This fragment of mouse plasminogen, as well as the human equivalent, includes four out of the five kringle domains of plasminogen.
The inhibition of angiogenesis by angiostatin is directly related to inhibiting the proliferation of endothelial cells. Because tumor growth is known to be angiogenesis dependent, it was initially hypothesized that the inhibitory properties of angiostatin would have clinical utility in arresting various cancers that are expressed as solid tumors. Studies performed in animal model systems have since demonstrated that recombinant angiostatin effectively suppresses tumor growth and metastasis.
Numerous enzymes have been identified which will convert plasminogen to angiostatin or at least to angiostatin-like fragments. The enzymes include several matrix metalloproteinases as well as urokinase and a tumor cell-derived reductase. The precise enzyme or mechanism which is responsible for the formation of angiostatin in vivo is unknown and it is believed that there may be multiple pathways for the conversion of plasminogen to angiostatin.
Structure/function studies have indicated that the first three kringle domains (and not the fourth) are responsible for the inhibitory properties of angiostatin, and that removal of the fourth kringle domain may actually yield a more potent inhibitor.
Our ""angiostatin"" product is produced by limited proteolysis of purified human glu-plasminogen using a proprietary enzyme preparation. The NH2-terminal sequence of this fragment is identical to human glu-plasminogen (Glu-1) and the molecule terminates at proline-452 thus making it larger than the ""natural"" or elastase derived product with an apparent molecular weight of about 50,000. Like authentic angiostatin, this product demonstrates an antiproliferative effect when tested in a growth factor-induced endothelial cell proliferation assay. The product is formulated in 20mM Hepes, 0.15M NaCl, pH 7.4, and should be stored frozen at -70 C or below.
Click Here for SDS
产品留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!
相关产品
Uterine Cancer Human Serum IUTC-SER
Uterine Cancer Human Plasma IUTC-N
Thyroid Cancer Human Serum ITHYC-SER
Thyroid Cancer Human Plasma ITHYC-N
Prostate Cancer Human Serum IPSTC-SER
Ovarian Cancer Human Serum IOVC-SER
Ovarian Cancer Human Plasma IOVC-N
Lung Cancer Human Serum ILNGC-SER
Lung Cancer Human Plasma ILNGC-N
Kidney Cancer Human Serum IHKDC-SER
Kidney Cancer Human Plasma IHKDC-N
Head and Neck Cancer Human Serum IHDNK-SER
Head and Neck Cancer Human Plasma IHDNK-N
Colon Cancer Human Serum ICTS-SER
Colon Cancer Human Plasma ICTS-N
Breast Cancer Human Serum IBSC-SER
Breast Cancer Human Plasma IBSC-N
Bladder Cancer Human Serum IBLDC-SER
Bladder Cancer Human Plasma IBLDC-N
Ulcerative Colitis Human Serum IPLA-UC-SER
Ulcerative Colitis Human Plasma IPLA-UC-N
Rheumatoid Arthritis Human Serum IPLA-RA-SER
Rheumatoid Arthritis Human Plasma IPLA-RA-N
Pulmonary Fibrosis Human Serum IPLA-PF-SER
Pulmonary Fibrosis Human Plasma IPLA-PF-N
Psoriasis Human Serum IPLA-PSRS-SER
Psoriasis Human Plasma IPLA-PSRS-N
Prostatitis Human Serum IPLA-PSTS-SER
Prostatitis Human Plasma IPLA-PSTS-N
Osteoporosis Human Serum IPLA-OSTO-SER
Copyright@ 2003-2026
上海拜力生物科技有限公司
版权所有
本公司网站所展示销售的产品仅供科研!
沪ICP备08023583号-12
沪公网安备 31011202007337号